ID
21490
Descripción
This Study is Being Performed to Evaluate the Effect of Genasense on the Efficacy and the Safety of Rituximab/Fludarabine Combination Treatment in Previously Untreated Subjects With Chronic Lymphocyctic Leukemia(CLL); ODM derived from: https://clinicaltrials.gov/show/NCT00517218
Link
https://clinicaltrials.gov/show/NCT00517218
Palabras clave
Versiones (1)
- 24/4/17 24/4/17 -
Subido en
24 de abril de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Lymphocytic Leukemia NCT00517218
Eligibility Lymphocytic Leukemia NCT00517218
- StudyEvent: Eligibility
Descripción
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Descripción
Absolute lymphocyte count
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C3544087
Descripción
Chemotherapy Chronic Lymphocytic Leukemia | Therapeutic procedure Chronic Lymphocytic Leukemia | Transplantation, Homologous
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0392920
- UMLS CUI [1,2]
- C0023434
- UMLS CUI [2,1]
- C0087111
- UMLS CUI [2,2]
- C0023434
- UMLS CUI [3]
- C0040739
Descripción
major surgery
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0679637
Descripción
Operative Surgical Procedures Adverse effects Serious | Recovering failed
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0543467
- UMLS CUI [1,2]
- C0879626
- UMLS CUI [1,3]
- C0205404
- UMLS CUI [2,1]
- C0521108
- UMLS CUI [2,2]
- C0231175
Descripción
Autoimmune hemolytic anemia | Autoimmune thrombocytopenia
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0002880
- UMLS CUI [2]
- C0242584
Descripción
Communicable Disease Serious | Anti-infective therapy Systemic Patient need for
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0009450
- UMLS CUI [1,2]
- C0205404
- UMLS CUI [2,1]
- C1141958
- UMLS CUI [2,2]
- C0205373
- UMLS CUI [2,3]
- C0686904
Similar models
Eligibility Lymphocytic Leukemia NCT00517218
- StudyEvent: Eligibility
C0332155 (UMLS CUI [1,2])
C0023434 (UMLS CUI [2,1])
C0205103 (UMLS CUI [2,2])
C1514715 (UMLS CUI [2,3])
C0023434 (UMLS CUI [3,1])
C0332167 (UMLS CUI [3,2])
C1514715 (UMLS CUI [3,3])
C0023434 (UMLS CUI [2])
C1514873 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C0023434 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C0023434 (UMLS CUI [2,2])
C0040739 (UMLS CUI [3])
C0879626 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,3])
C0521108 (UMLS CUI [2,1])
C0231175 (UMLS CUI [2,2])
C0242584 (UMLS CUI [2])
C0205404 (UMLS CUI [1,2])
C1141958 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
C0686904 (UMLS CUI [2,3])